Physician profile
Timothy Michael Hunter
NPI 1861491771
$1,776.65
in general payments reported to CMS, 2019-2025
15 companies · $117 in 2025
The $117 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $673 · 2020: $14.11 · 2023: $601 · 2024: $372 · 2025: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,090.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,089.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $260.50 | 2023-2024 | |
| Astrazeneca Pharmaceuticals LP | $246.75 | 2019-2024 | Farxiga |
| Amgen INC. | $227.46 | 2019-2023 | Repatha |
| Merck Sharp & Dohme LLC | $184.14 | 2019 | |
| Phathom Pharmaceuticals, INC. | $125.65 | 2024 | Voquezna |
| Pfizer INC. | $125.46 | 2019 | |
| Idorsia Pharmaceuticals US INC | $125.00 | 2023 | Quviviq |
| Novo Nordisk INC | $110.92 | 2023 | |
| Stryker Corporation | $103.04 | 2019 | |
| Lilly USA, LLC | $97.88 | 2025 | Zepbound |
| Nevro Corp. | $57.52 | 2019 | |
| Amarin Pharma, INC. | $56.04 | 2019 | |
| Abbott Laboratories | $22.66 | 2019 | |
| Exact Sciences Corporation | $19.52 | 2025 | Cologuard Collection Kit |
| Boston Scientific Corporation | $14.11 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.